The content on this site is intended for healthcare professionals only
Dr Dobson talks to ecancertv at EBCC 9 about screening programmes across Europe and tackling overdiagnosis.
She covers a DCIS study from the Netherlands, evidence for avoiding unnecessary radiotherapy and a 3 pronged attack to identify groups of abnormalities by a careful re-labelling sub groups of those being screened.
BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
Genomic testing: Awareness and effective communication between healthcare professionals and patients
Community-based breast cancer control programme in the Philipines
Initiatives for cancer control in Indonesia
PHERGain trial ID's early breast cancer cases that benefit from dual HER2 blockade without chemo
Tomosynthesis guided biopsy
Evidence-based approach to lymph node assessment and targeted axillary dissection
Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery
HER2DX confirms the ability of the test to predict long-term survival and response to anti-HER2 therapy in BC
